Clinical trials
Metabolic Syndrome trials in Canada with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
61 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 2 |
| 2005 | 1 |
| 2007 | 4 |
| 2008 | 3 |
| 2009 | 5 |
| 2010 | 1 |
| 2011 | 3 |
| 2012 | 3 |
| 2013 | 4 |
| 2014 | 4 |
| 2016 | 4 |
| 2017 | 3 |
| 2018 | 6 |
| 2019 | 4 |
| 2020 | 3 |
| 2021 | 3 |
| 2022 | 1 |
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 46 |
| Unknown status | 4 |
| Active, not recruiting | 3 |
| Withdrawn | 2 |
| Recruiting | 2 |
| Not yet recruiting | 2 |
| Terminated | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Laval University | 16 |
| University of Toronto | 9 |
| University of Manitoba | 4 |
| Montreal Heart Institute | 2 |
| Queen's University | 2 |
| Unity Health Toronto | 2 |
| University Health Network, Toronto | 2 |
| University of British Columbia | 2 |
| University of Calgary | 2 |
| University of Guelph | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Metabolic Syndrome | 61 |
| Obesity | 19 |
| Cardiovascular Diseases | 13 |
| Diabetes Mellitus | 11 |
| Insulin Resistance | 11 |
| Overweight | 10 |
| Hypertension | 5 |
| Diabetes Mellitus, Type 2 | 4 |
| Endotoxemia | 4 |
| Inflammation | 4 |
Trials
Showing 1 to 25 of 61. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.